Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes

Abstract

To investigate the relationship between the fetal hemoglobin-containing erythroblasts (F blasts) and apoptosis in myelodysplastic syndromes (MDS), we immunohistochemically assessed F blasts, F cells, and apoptosis in 137 patients with MDS. A marked increase in the number of F blasts in the bone marrow was identified in 116 of 137 patients (84.7%), and the number of F cells was elevated in 54 patients (39.4%). Among the erythroblasts stained by anti-glycophorin C antibody, the mean percentage of F blasts was 14.63 ± 9.17% in MDS, which was significantly higher than that in non-MDS patients with stress erythropoiesis (4.82 ± 3.35%, P < 0.01), although there were no significant differences in the number of F cells between these groups. In particular, 62 of the 137 MDS patients (45.3%) had an apparent increase in F blasts but no elevation of F cells. The apoptotic rate was significantly higher in the patients with a F blast/F cell (Fb/Fc) ratio 5.0 than in those with a Fb/Fc ratio <1.0 (P < 0.01). The results indicate that F cell precursors are incapable of maturing into functioning end-stage F cells, presumably owing to apoptotic cell death. The measurement of F blasts in the bone marrow is needed for the precise evaluation of fetal-type erythropoiesis in MDS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Bard H . The postnatal decline of hemoglobin F synthesis in normal full-term infants J Clin Invest 1975 55: 395–398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Boyer SH, Belding TK, Margolet L, Noyes AN . Fetal hemoglobin restriction to a few erythrocytes (F-cells) in normal human adults Science 1975 188: 361–363

    Article  CAS  PubMed  Google Scholar 

  3. Wood WG, Stomatoyannopoulos G, Lim G, Nute PE . F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F Blood 1975 46: 671–682

    CAS  PubMed  Google Scholar 

  4. Jane SM, Cunningham JM . Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies Br J Haematol 1998 102: 415–422

    Article  CAS  PubMed  Google Scholar 

  5. Stamatoyannopoulos G, Veith R, Galanello R, Papayannopoulou T . HbF production in stressed erythropoiesis: observations and kinetic models Ann NY Acad Sci 1985 445: 188–197

    Article  CAS  PubMed  Google Scholar 

  6. Bard H, Gagnon C, Peri KG . HbF synthesis during stress erythropoiesis as determined by gamma-RNA/non-alpha-mRNA quantification Pediatr Res 1999 45: 684–686

    Article  CAS  PubMed  Google Scholar 

  7. Reinhardt D, Haase D, Schoch C, Wollenweber S, Hinkelmann E, Heyden WV, Lentini G, Wormann B, Schroter W, Pekrun A . Hemoglobin F in myelodysplastic syndrome Ann Hematol 1998 76: 135–138

    Article  CAS  PubMed  Google Scholar 

  8. Betke K, Marti HR, Schlicht J . Estimation of small percentage of foetal haemoglobin Nature 1959 184: 1877–1878

    Article  CAS  PubMed  Google Scholar 

  9. Bourantas KL, Gergiou J, Seferiadis K . Quantitation of HbF-chain types by HPLC in patients with myelodysplastic syndrome Haematologica 1991 76: 337–338

    CAS  PubMed  Google Scholar 

  10. Bisse E, Wieland H . High-performance liquid chromatographic separation of human haemoglobins: simultaneous quantitation of foetal and glycated haemoglobins J Chromatogr 1988 434: 95–110

    Article  CAS  PubMed  Google Scholar 

  11. Epstein N, Epstein M, Boulet A, Fibach E, Rodgers GP . Monoclonal antibody-based methods for quantitation of hemoglobin: application to evaluating patients with sickle cell anemia treated with hydroxyurea Eur J Haematol 1996 57: 17–24

    Article  CAS  PubMed  Google Scholar 

  12. Campbell TA, Ware RE, Mason M . Detection of hemoglobin variants in erythrocytes by flow cytometry Cytometry 1999 35: 242–248

    Article  CAS  PubMed  Google Scholar 

  13. Chen JC, Bigelow N, Davis BH . Proposed flow cytometric reference method for the determination of erythroid F-cell counts Cytometry 2000 42: 239–246

    Article  CAS  PubMed  Google Scholar 

  14. Choi JW, Kim Y, Fujino M, Ito M . A new anti-hemoglobin F antibody against synthetic peptide for the detection of F-cell precursors (F-blasts) in bone marrow Int J Hematol 2001 74: 277–280

    Article  CAS  PubMed  Google Scholar 

  15. Parker JE, Mufti GJ . Ineffective haematopoiesis and apoptosis in myelodysplastic syndromes Br J Haematol 1998 101: 220–230

    Article  CAS  PubMed  Google Scholar 

  16. Parcharidou A, Raza A, Economopoulos T, Papageorgiou E, Anagnostou D, Papadaki T, Raptis S . Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes Eur J Haematol 1999 62: 19–26

    Article  CAS  PubMed  Google Scholar 

  17. Kudo S, Harigae H, Watanabe N, Takasawa N, Kimura J, Kameoka J, Meguro K, Imaizumi M, Kaku M, Sasaki T . Increased HbF levels in dyserythropoiesis Clin Chim Acta 2000 291: 83–87

    Article  CAS  PubMed  Google Scholar 

  18. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L . Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis Exp Cell Res 1996 226: 387–397

    Article  CAS  PubMed  Google Scholar 

  19. Newman DR, Pierre RV, Linman JW . Studies on the diagnostic significance of hemoglobin F levels Mayo Clin Proc 1973 48: 199–202

    CAS  PubMed  Google Scholar 

  20. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessells JM . Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system Blood 1995 85: 1742–1750

    CAS  PubMed  Google Scholar 

  21. Craig JE, Sampietro M, Oscier DG, Contreras M, Thein SL . Myelodysplastic syndrome with karyotype abnormality is associated with elevated F-cell production Br J Haematol 1996 93: 601–605

    Article  CAS  PubMed  Google Scholar 

  22. Haase D, Fonatsch C, Freund M, Wormann B, Bodenstein H, Bartels H, Stollmann-Gibbels B, Lengfelder E . Cytogenetic findings in 179 patients with myelodysplastic syndromes Ann Hematol 1995 70: 171–187

    Article  CAS  PubMed  Google Scholar 

  23. Shetty V, Hussaini S, Broady-Robinson L, Allampallam K, Mundle S, Borok R, Broderick E, Mazzoran L, Zorat F, Raza A . Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates Blood 2000 96: 1388–1392

    CAS  PubMed  Google Scholar 

  24. Tsoplou P, Kouraklis-Symeonidis A, Thanopoulou E, Zikos P, Orphanos V, Zoumbos NC . Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in good vs poor prognosis patients and correlation with apoptosis-related genes Leukemia 1999 13: 1554–1563

    Article  CAS  PubMed  Google Scholar 

  25. Yoshida Y, Mufti GJ . Apoptosis and its significance in MDS: controversies revisited Leuk Res 1999 23: 777–785

    Article  CAS  PubMed  Google Scholar 

  26. Merchant SH, Gonchoroff NJ, Hutchison RE . Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes Cytometry 2001 46: 28–32

    Article  CAS  PubMed  Google Scholar 

  27. Shimazaki K, Ohshima J, Suzumiya C, Kawasaki C, Kikuchi M . Evaluation of apoptosis as a prognostic factor in myelodysplasitc syndromes Br J Haematol 2000 110: 584–590

    Article  CAS  PubMed  Google Scholar 

  28. Raza A, Gezer S, Mundle S, Gao X, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H . Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes Blood 1995 86: 268–276

    CAS  PubMed  Google Scholar 

  29. Lepelley P, Campergue L, Grardel N, Preudhomme C, Cosson A, Fenaux P . Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol 1996 95: 368–371

    Article  CAS  PubMed  Google Scholar 

  30. Weinberg RS, Goldberg JD, Schofield JM, Lenes AL, Styczynski R, Alter BP . Switch from fetal to adult hemoglobin is associated with a change in progenitor cell population J Clin Invest 1983 71: 785–794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Koc A, Oner R, Oner D, Aktas D, Sozen M, Tuncbilek E, Altay C . Myelodysplastic sydrome (MDS) associated with increased hemoglobin F and trisomy 8: presentation of a patient Hematol Cell Ther 1999 41: 187–189

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from DAIKO Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, J., Kim, Y., Fujino, M. et al. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes. Leukemia 16, 1478–1483 (2002). https://doi.org/10.1038/sj.leu.2402536

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402536

Keywords

This article is cited by

Search

Quick links